Facial dysmorphism-shawl scrotum-joint laxity syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1778Q87.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Facial dysmorphism-shawl scrotum-joint laxity syndrome, also known as Aarskog-Scott syndrome or faciogenital dysplasia, is a rare genetic disorder that primarily affects males and is characterized by a distinctive combination of facial, skeletal, and genital abnormalities. The condition was first described by Dagfinn Aarskog in 1970 and further characterized by Charles Scott. Key facial features include a round face, hypertelorism (widely spaced eyes), a broad nasal bridge, a short nose with anteverted nostrils, and a long philtrum. The hallmark genital finding is the 'shawl scrotum,' in which the scrotal skin surrounds the base of the penis. Joint hyperlaxity (looseness of the joints) is another prominent feature, along with short stature, brachydactyly (short fingers), and interdigital webbing. The syndrome affects multiple body systems including the musculoskeletal system, craniofacial structures, and the genitourinary system. Additional features may include mild to moderate short stature, a widow's peak hairline, ptosis (drooping eyelids), and mild cognitive or behavioral difficulties in some individuals, though intelligence is often normal. Skeletal findings can include cervical vertebral anomalies and pectus excavatum. Growth may be delayed during childhood but can improve during puberty. There is no specific cure for this condition. Management is supportive and symptom-based, potentially involving growth hormone therapy for significant short stature, surgical correction of genital or skeletal anomalies, orthodontic treatment, and educational support when needed. Regular monitoring by a multidisciplinary team including geneticists, endocrinologists, and orthopedic specialists is recommended. The prognosis is generally favorable, with most affected individuals having a normal lifespan.

Also known as:

Clinical phenotype terms— hover any for plain English:

Shawl scrotumHP:0000049
Inheritance

X-linked recessive

Carried on the X chromosome; typically affects males more than females

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Facial dysmorphism-shawl scrotum-joint laxity syndrome.

View clinical trials →

No actively recruiting trials found for Facial dysmorphism-shawl scrotum-joint laxity syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Facial dysmorphism-shawl scrotum-joint laxity syndrome community →

No specialists are currently listed for Facial dysmorphism-shawl scrotum-joint laxity syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Facial dysmorphism-shawl scrotum-joint laxity syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Facial dysmorphism-shawl scrotum-joint laxity syndromeForum →

No community posts yet. Be the first to share your experience with Facial dysmorphism-shawl scrotum-joint laxity syndrome.

Start the conversation →

Latest news about Facial dysmorphism-shawl scrotum-joint laxity syndrome

No recent news articles for Facial dysmorphism-shawl scrotum-joint laxity syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Facial dysmorphism-shawl scrotum-joint laxity syndrome

What is Facial dysmorphism-shawl scrotum-joint laxity syndrome?

Facial dysmorphism-shawl scrotum-joint laxity syndrome, also known as Aarskog-Scott syndrome or faciogenital dysplasia, is a rare genetic disorder that primarily affects males and is characterized by a distinctive combination of facial, skeletal, and genital abnormalities. The condition was first described by Dagfinn Aarskog in 1970 and further characterized by Charles Scott. Key facial features include a round face, hypertelorism (widely spaced eyes), a broad nasal bridge, a short nose with anteverted nostrils, and a long philtrum. The hallmark genital finding is the 'shawl scrotum,' in which

How is Facial dysmorphism-shawl scrotum-joint laxity syndrome inherited?

Facial dysmorphism-shawl scrotum-joint laxity syndrome follows a x-linked recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Facial dysmorphism-shawl scrotum-joint laxity syndrome typically begin?

Typical onset of Facial dysmorphism-shawl scrotum-joint laxity syndrome is neonatal. Age of onset can vary across affected individuals.